Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma [3]

Leukemia and Lymphoma

Volumn 45, Issue 7, 2004, Pages 1497-1499

  Novella, Elisabetta ^a   Madeo, Domenico ^a   Albiero, Elena ^a   Roberti, Sara ^a   Castaman, Giancarlo ^a   Elice, Francesca ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

DCEP regimen; Flow cytometry; Multiple myeloma; Peripheral blood stem cell; Stem cell mobilization

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; SYNDECAN 1; VINCRISTINE;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW PURGING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; HUMAN; IN VIVO STUDY; LETTER; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VINCRISTINE;

EID: 2542573930     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001663644     Document Type: Letter

References (8)

1. Corso, A., Arcaini, L., Caberlon, S., Zappasodi, P., et al. (2002) "A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma", Haematologica, 87, 1041-1045.
2. Vescio, R.A., Han, E.J., Schiller, G.J., Lee, J.C., et al. (1996) "Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts", Bone Marrow Transplant., 18, 103-110.
3. Dyson, P.G., Horvath, N., Joshua, D., Barrow, L., et al. (2000) "CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma", Bone Marrow Transplant., 25, 1175-1184.
4. Mitterer, M., Oduncu, F., Lanthaler, J., Drexler, E., et al. (1999) "The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients", Br. J. Haematol., 106, 737-743.
5. Gertz, M.A., Witzig, T.E., Pineda, A.A., Greipp, P.R., et al. (1997) "Monoclonal plasmacells in the peripheral blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse free survival after transplantation", Bone Marrow Transplant., 19, 337-342.
6. Stelzer, G.T., Marti, G., Hurley, A., McCoy, P. Jr., et al. (1997) "US-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures", Cytometry, 30, 214-230.
7. Rawstron, A.C., Davies, F.E., DasGupta, R., Ashcrof, A.J., et al. (2002) "Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation", Blood, 100, 3095-3100.
8. Scheneider, U., van Lessen, A., Hun, D. and Serke, S. (1997) "Two Subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen", Br. J. Haematol., 97, 56-64.